Association of Latin-American Ethnicity with an Increase in Weight in an HIV-Infected Outpatient Population

M. C. Jiménez, Victoria Alcázar Lázaro, R. T. Perea
{"title":"Association of Latin-American Ethnicity with an Increase in Weight in an HIV-Infected Outpatient Population","authors":"M. C. Jiménez, Victoria Alcázar Lázaro, R. T. Perea","doi":"10.31038/idt.2022312","DOIUrl":null,"url":null,"abstract":"Objective: To explore weight gain in regular practice involving naïve patients, those who continue the same treatment for at least 6 months or those who changed their antiretroviral treatment. Methods: We performed a retrospective analysis of patients followed-up between 2013 and 2019. This study included 3 groups of participants (naïve patients, those who had been on viral suppression for more than 6 months, and those with a treatment change). Results: 317 people living with HIV (PLHIV) participated. The proportion of participants in the overweight and obese categories increased over time, from 40 to 43% and from 9.46% to 12.43% respectively. Proportion of metabolic syndrome increased overtime from 3.79 to 6.22%. Stratification by both sex and ethnicity, showed the greatest weight gain among Latin male. Considering the risk factors for HIV infection, men that had sex with men (MSM) and heterosexual patients gained 2.03 (95% CI, 0.42-3.65; p =0.013) and 1.57 (95% CI 0.12-3.02; p =0.034) kg more than those who were former intravenous kg Elvitegravir suggest that there are demographic, HIV and treatment related contributors to weight gain in PLHIV. Latin-American ethnic associated gain, in male sex. We could not find any association of weight gain with sex, age or group of treatment six months or change of We found boosted PI-based regimens, LPV/r, EVG/c and RPV, and TAF among nucleoside reverse transcriptase inhibitors (NRTI) associated with the gain. clinical maintenance healthy weight implement for patients starting treatment but also for those with a long experience in antiretroviral treatment.","PeriodicalId":87272,"journal":{"name":"Infectious diseases and therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31038/idt.2022312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore weight gain in regular practice involving naïve patients, those who continue the same treatment for at least 6 months or those who changed their antiretroviral treatment. Methods: We performed a retrospective analysis of patients followed-up between 2013 and 2019. This study included 3 groups of participants (naïve patients, those who had been on viral suppression for more than 6 months, and those with a treatment change). Results: 317 people living with HIV (PLHIV) participated. The proportion of participants in the overweight and obese categories increased over time, from 40 to 43% and from 9.46% to 12.43% respectively. Proportion of metabolic syndrome increased overtime from 3.79 to 6.22%. Stratification by both sex and ethnicity, showed the greatest weight gain among Latin male. Considering the risk factors for HIV infection, men that had sex with men (MSM) and heterosexual patients gained 2.03 (95% CI, 0.42-3.65; p =0.013) and 1.57 (95% CI 0.12-3.02; p =0.034) kg more than those who were former intravenous kg Elvitegravir suggest that there are demographic, HIV and treatment related contributors to weight gain in PLHIV. Latin-American ethnic associated gain, in male sex. We could not find any association of weight gain with sex, age or group of treatment six months or change of We found boosted PI-based regimens, LPV/r, EVG/c and RPV, and TAF among nucleoside reverse transcriptase inhibitors (NRTI) associated with the gain. clinical maintenance healthy weight implement for patients starting treatment but also for those with a long experience in antiretroviral treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
拉丁美洲种族与艾滋病毒感染门诊人群体重增加的关系
目的:探讨naïve患者、继续相同治疗至少6个月或改变抗逆转录病毒治疗的患者在常规实践中体重增加的情况。方法:对2013 - 2019年随访的患者进行回顾性分析。这项研究包括三组参与者(naïve患者,病毒抑制超过6个月的患者,以及改变治疗的患者)。结果:317名HIV感染者(PLHIV)参与调查。随着时间的推移,超重和肥胖类别的参与者比例分别从40%增加到43%和从9.46%增加到12.43%。代谢综合征的比例从3.79%增加到6.22%。按性别和种族分层,拉丁裔男性体重增加最多。考虑到HIV感染的危险因素,男男性行为者(MSM)和异性恋患者增加2.03 (95% CI, 0.42-3.65;p =0.013)和1.57 (95% CI 0.12-3.02;p =0.034) kg比前静脉注射Elvitegravir的患者体重增加,这表明PLHIV患者体重增加与人口统计学、HIV和治疗相关。拉丁美洲种族相关的增益,在男性中。我们没有发现体重增加与性别、年龄或治疗6个月的组或变化有任何关联。我们发现核苷逆转录酶抑制剂(NRTI)中增加的pi方案、LPV/r、EVG/c和RPV以及TAF与体重增加有关。临床维持健康体重适用于开始治疗的患者,也适用于长期接受抗逆转录病毒治疗的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Commentary on “The Clinical Syndromes Produced by the Offensive Biological Agents” SARS-CoV-2 Infection and Multiple Sclerosis: Proactive Approach in a Vulnerable Patient Group through Daily Vitamin D Supplementation? Febrile Neutropenia in Pediatric Oncology: Prevalence and Risk-Factors for Bacterial and Fungal Infection Community and Home Based Palliative Care Services: The Key to Equitable Access to Healthcare Services Chronic Hepatitis B and Hepatocellular Carcinoma: Novel Therapeutic Concepts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1